Skeletal Muscle Insulin Resistance Is the Primary Defect in Type 2 Diabetes
Open accessThe DOI matches its Crossref record; 110 of the 115 references it cites were found in a registry or an index; 22 of the 65 sources its claims cite were checked for support.
Abstract
Insulin resistance is a characteristic feature of type 2 diabetes and plays a major role in the pathogenesis of the disease (1,2). Although �-cell failure is the sine qua non for development of type 2 diabetes, skeletal muscle insulin resistance is considered to be the initiating or primary defect that is evident decades before �-cell failure and overt hyperglycemia develops (3,4). Insulin resistance is defined as a reduced response of target tissues (compared with subjects with normal glucose tolerance [NGT] without a family history of diabetes), such as the skeletal muscle, liver, and adipocytes, to
Overview
CoChat Summary
TL;DR
This review argues that skeletal muscle insulin resistance—especially impaired glycogen synthesis—is the initiating/primary defect in most type 2 diabetes, preceding β-cell failure and overt hyperglycemia. It concludes that overt diabetes requires β-cell failure to supervene, while muscle insulin resistance is already evident in normal glucose-tolerant high-risk relatives and prospective populations.
Key findings
- Skeletal muscle is the predominant site of insulin-mediated postprandial glucose uptake: under euglycemic hyperinsulinemia, ∼80% of glucose uptake occurs in skeletal muscle; leg muscle glucose uptake plateaus at ∼10 mg/kg leg weight per minute after 60 min, and in lean type 2 diabetic subjects it is reduced by ∼50% during the last hour of the insulin clamp.
- In lean NGT offspring of two type 2 diabetic parents, a two-step euglycemic clamp (20 and 40 mU/m² per min; plasma insulin ∼40 and ∼80 μU/ml) showed glucose uptake decreased by 33% and 43%, respectively; the impairment was accounted for entirely by reduced nonoxidative glucose metabolism/glycogen synthesis, with no defect in insulin suppression of hepatic glucose production.
- Prospective Pima Indian data showed both progressors and nonprogressors had a further 11–14% reduction in insulin sensitivity; nonprogressors increased insulin secretion by 30%, whereas progression to type 2 diabetes was associated with a 78% decline in the acute insulin response to intravenous glucose.
- Hyperinsulinemia itself worsens muscle insulin resistance: a 72 pmol/l (11 μU/ml) increase in plasma insulin for 72–96 h reduced insulin-stimulated glucose disposal by 30–40%, entirely via impaired nonoxidative glucose disposal; in rats, 7-day hyperinsulinemia reduced total-body glucose uptake, storage, and glycolysis by 39%, 62%, and 26%. Mitochondrial ATP production increased by 90% in NGT subjects without family history but only 5% in insulin-resistant offspring.
Methods
- Narrative review/symposium article; no primary study design or new sample. It synthesizes human studies using the euglycemic insulin clamp (described as the gold standard), indirect calorimetry, muscle biopsy, femoral/forearm catheterization, PET, NMR spectroscopy, OGTT, and prospective follow-up.
- Populations discussed include lean NGT first-degree relatives/offspring of two type 2 diabetic parents, Mexican Americans, Pima Indians, Caucasians in San Antonio, and type 2 diabetic subjects. Main analysis is qualitative synthesis of cited evidence.
Limitations
- Stated: by the time hyperglycemia is manifest, multiple abnormalities (elevated glucose, FFA, and cytokines) coexist, making it extremely difficult to separate each defect’s contribution; at initial presentation it is not possible to define which defect came first.
- Stated: it is unclear whether mitochondrial dysfunction leads to increased intramyocellular lipid and insulin resistance or increased muscle lipid leads to mitochondrial dysfunction and insulin resistance (“which is the cart and which is the horse”).
- Evident: as a narrative review, it lacks systematic search, formal quality assessment, or meta-analysis; conclusions depend on selected cited studies, and several figures are in an online appendix rather than the text.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
14 Valid · 1 Not valid · 22 Not checked · 11 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In type 2 diabetes, impaired glycogen synthesis secondary to reduced glycogen synthase activity is the earliest detectable metabolic defect ( 39 – 41 ).”
What the sources say
- Not matchedcites [39] DeFronzo, 1997, Pathogenesis of type 2 diabetes: metabolic and molecular implications for identifying genes, Diabetes Rev
We searched by its title and found no matching paper.
- Partly supportedcites [40] Bogardus, 1984, Correlation between muscle glycogen synthase activity and in vivo insulin action in man, J Clin Invest sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) reports a correlation between muscle glycogen synthase activity and insulin-mediated glucose storage in glucose-tolerant and diabetic subjects. It hypothesizes a link between reduced enzyme activity and impaired glucose handling, but does not establish that one causes the other or that impaired glycogen synthesis is the earliest detectable metabolic defect in type 2 diabetes. (LLM, conf=0.86)
- Not checked — no full text of the sourcecites [41] Shulman, 1990, Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy, N Engl J Med source
states a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Not matched
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Maintaining the integrity of the IRS-1/PI-3 kinase/Akt pathway is essential for normal insulin-mediated glucose uptake in skeletal muscle ( 26 ).”
What the sources say
- Partly supportedcites [26] Krook, 2000, Characterization of signal transduction and glucose transport in skeletal muscle from type 2 diabetic patients, Diabetes sourceExperimental — accuracy not yet measured
The paper’s introduction identifies IRS-1 and PI 3-kinase as components of insulin signaling involved in skeletal-muscle glucose transport. Its study summary says reduced PI 3-kinase activity may partly account for reduced insulin-stimulated glucose transport, while additional defects contribute. The cited passages do not establish a role for Akt or show that integrity of the entire pathway is essential for normal uptake. (LLM, conf=0.88)
states a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Multiple investigators unequivocally have demonstrated that lean NGT offspring of two parents with type 2 diabetes exhibit moderate to severe skeletal muscle insulin resistance ( 28 – 33 ).”
What the sources say
- Not checked — no full text of the sourcecites [28] Perseghin, 1997, Metabolic defects in lean nondiabetic offspring of NIDDM parents: a cross-sectional study, Diabetes source
- Not checked — no full text of the sourcecites [29] Ferrannini, 2003, Influence of ethnicity and familial diabetes on glucose tolerance and insulin action: a physiological analysis, J Clin Endocrinol Metab source
- Not checked — no full text of the sourcecites [30] Kashyap, 2004, Discordant effects of a chronic physiological increase in plasma FFA on insulin signaling in healthy subjects with or without a family history of type 2 diabetes, Am J Physiol Endocrinol Metab source
- Partly supportedcites [31] Vaag, 1992, Decreased insulin activation of glycogen synthase in skeletal muscles in young nonobese Caucasian first-degree relatives of patients with non-insulin-dependent diabetes mellitus, J Clin Invest sourceExperimental — accuracy not yet measured
The Subjects section says the participants were nonobese, had normal oral glucose tolerance, and had at least one parent with NIDDM—not necessarily two. The Discussion reports skeletal-muscle insulin resistance but also considerable overlap with controls; it does not establish moderate-to-severe resistance in offspring of two affected parents. Page numbers are unavailable in our copy. (LLM, conf=0.88)
- Not checked — no full text of the sourcecites [32] Gulli, 1992, The metabolic profile of NIDDM is fully established in glucose-tolerant offspring of two Mexican-American NIDDM parents, Diabetes source
- Not checked — no full text of the sourcecites [33] Tripathy, 2003, Familiality of metabolic abnormalities is dependent on age at onset and phenotype of the type 2 diabetic proband, Am J Physiol source
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Every source the paper cites for this claim was checked and supports it.
In the paper
“In lean insulin-resistant NGT offspring of type 2 diabetic parents, increased serine phosphorylation of IRS-1 in skeletal muscle has been documented in association with impaired activation of Akt ( 57 ) (Fig. A11).”
What the sources say
- Supportedcites [57] Morino, 2005, Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents, J Clin Invest source
The Introduction describes the offspring as young, lean, normoglycemic, and insulin-resistant. The Results report increased IRS-1 serine phosphorylation and reduced insulin-stimulated Akt phosphorylation in the offspring, and the Discussion explicitly describes these findings as associated. Page numbers are not provided in our copy. (LLM, conf=0.94)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“This observation is of important clinical significance, since diacylglycerol, long-chain fatty acyl CoAs, and ceramides all have been shown to cause serine phosphorylation of insulin resistance and IRS-1 and lead to the development of insulin resistance in skeletal muscle ( 59 , 60 ).”
What the sources say
- Not checked — no full text of the sourcecites [59] Hotamisligil, 1996, IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance, Science source
- Partly supportedcites [60] Jiang, 1999, Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats, J Clin Invest sourceExperimental — accuracy not yet measured
The Discussion says elevated free fatty acids may impair insulin’s metabolic action and notes protein kinase C activation in skeletal muscle. It does not say that diacylglycerol, long-chain fatty acyl CoAs, or ceramides cause IRS-1 serine phosphorylation and thereby produce skeletal-muscle insulin resistance; its serine-phosphorylation discussion concerns the insulin receptor instead. Page numbers are unavailable in our copy. (LLM, conf=0.83)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
21 more claims · 6 with their cited sources checked
Create a free account to see all 48 claims and to verify the 1 reference still open.
- Probably not a substantial claim. 4
- It may state two separate claims as one. 20
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Various epidemiological and experimental studies have shown that muscle weakness, decreased muscle mass, reduced activation of glycogen synthase, and alterations in the numbers of glycolytic skeletal muscle fibers are related to, and may precede, insulin resistance, glucose intolerance, and T2D [332,333].”
From Global consensus on optimal exercise recommendations for enhancing healthy longevity in older adults (ICFSR) (2025) · cites this paper as [333]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Even though pancreatic beta cell dysfunction is the main pathogenesis of type 2 diabetes mellitus, given that the uptake of postprandial glucose by skeletal muscles is approximately 80–90%, skeletal muscle IR plays a crucial role in the development and progression of diabetes mellitus [129,130].”
From Sarcopenic obesity, insulin resistance, and their implications in cardiovascular and metabolic consequences (2020) · cites this paper as [130]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Dysregulation of these processes contributes to the pathogenesis of numerous diseases, including diabetes and obesity (DeFronzo and Tripathy, 2009; Sugden et al., 2009), mitochondrial disorders (Kerr, 2013), cardiac failure (Fillmore and Lopaschuk, 2013), neurodegenerative disorders (Cunnane et al., 2011; Yao et al., 2011), and cancer (Currie et al., 2013; Tennant et al., 2010).”
From Regulation of Substrate Utilization by the Mitochondrial Pyruvate Carrier (2014) · cites this paper as DeFronzo and Tripathy, 2009
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Furthermore, the SM accounts for >80% of glucose uptake in the post-prandial period following an oral glucose load, with linear increases in uptake over time [17,20].”
From Optimised Skeletal Muscle Mass as a Key Strategy for Obesity Management (2025) · cites this paper as [20]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Skeletal muscle is the main tissue responsible for insulin-stimulated glucose disposal and an impaired uptake is common in obesity and has substantial impact on whole-body glucose turnover.8,9”
From Changes in lean body mass with glucagon‐like peptide ‐1‐based therapies and mitigation strategies (2024) · cites this paper as [8]
Experimental — accuracy not yet measured
7 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425 · cited 1×
“RESEARCH DESIGN AND METHODS — The euglycemic insulin clamp technique (5) is considered to be the gold standard for measuring insulin action in vivo.”
BackgroundSelf-citationMatsuda, M., & DeFronzo, R. A. (1999) · Diabetes Care · doi:10.2337/diacare.22.9.1462 · Cited by 5,621 · cited 1×
“70) with insulin sensitivity measured with the euglycemic insulin clamp (9).”
MethodSelf-citationKatz, A., Nambi, S. S., Mather, K., Baron, A. D., Follmann, D. A., Sullivan, G., & Quon, M. J. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.7.6661 · Cited by 3,931
Obesity and insulin resistance
Kahn, B. B., & Flier, J. S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10842 · Cited by 3,225
Critical nodes in signalling pathways: insights into insulin action
Taniguchi, C. M., Emanuelli, B., & Kahn, C. R. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1837 · Cited by 2,760 · cited 1×
“This results in activation of downstream protein kinase B (also called Akt) and phosphorylation of Akt substrate 160 (AS160), which facilitates the translocation of GLUT4 to the sarcolemma and subsequent entry of glucose into the cell (25).”
BackgroundHotamisligil, G. S., Peraldi, P., Budavari, A., Ellis, R., White, M. F., & Spiegelman, B. M. (1996) · Science · doi:10.1126/science.271.5249.665 · Cited by 2,630
The Triumvirate: β-Cell, Muscle, Liver: A Collusion Responsible for NIDDM
DeFronzo, R. A. (1988) · Diabetes · doi:10.2337/diab.37.6.667 · Cited by 2,456 · cited 7×
“Because the majority of type 2 diabetic subjects are obese, they also have daylong elevation of the plasma free fatty acid (FFA) concentration and increased circulating levels of inflammatory cytokines (1,2).”
BackgroundInfluentialSelf-citation
Research works printed but not linked: 2
- Pendergrass, 2007, Muscle glucose transport and phosphorylation in type 2 diabetic, obese nondiabetic, and genetically predisposed individuals, Am J Physiol Endocrinol Metab, 292, E92, 10.1152/ajpendo.00617.2005 · DOI · Paper page
- Morino, 2005, Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents, J Clin Invest, 115, 3587, 10.1172/jci25151 · DOI · Paper page
Cited by
Items 301–400 of 2,099
Nutrient Excess in AMPK Downregulation and Insulin Resistance.
Coughlan, K. A., Valentine, R. J., Ruderman, N. B., & Saha, A. K. (2013) · PubMed · Cited by 78
Huang, Y., Gao, S., Chen, J., Albrecht, E., Zhao, R., & Yang, X. (2017) · Oncotarget · doi:10.18632/oncotarget.14375 · Cited by 59
“Skeletal muscle is a primary site of glucose disposal and insulin action [32].”
BackgroundVarone, E., Pozzer, D., Modica, S. M. D., Chernorudskiy, A. L., Nogara, L., Baraldo, M., Cinquanta, M., Fumagalli, S., Villar‐Quiles, R. N., Simoni, M. G. D., et al. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101176 · Cited by 62
The effect of type 2 diabetes mellitus and obesity on muscle progenitor cell function
Teng, S., & Huang, P. (2019) · Stem Cell Research & Therapy · doi:10.1186/s13287-019-1186-0 · Cited by 59
Is Insulin Resistance a Feature of or a Primary Risk Factor for Cardiovascular Disease?
Laakso, M. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0684-4 · Cited by 74
Warren, B. E., Lou, P., Lucchinetti, E., Zhang, L., Clanachan, A. S., Affolter, A., Hersberger, M., Zaugg, M., & Lemieux, H. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00511.2013 · Cited by 62
“Insulin resistance is a major characteristic of T2DM and refers to the inability of cells to respond adequately to insulin, which consequently leads to impaired glucose uptake, reduced glucose clearance, and hyperinsulinemia (15, 51).”
BackgroundBittel, D. C., Bittel, A. J., Tuttle, L. J., Hastings, M. K., Commean, P. K., Mueller, M. J., Cade, W. T., & Sinacore, D. R. (2014) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2014.11.003 · Cited by 64
“…the lower extremity is a particularly important etiological factor in the onset and progression of type 2 diabetes (T2DM) and its complications due to its hormonal and structural influence on skeletal muscle – the tissue responsible for 90% of peripheral glucose uptake (DeFronzo & Tripathy, 2009).”
Albers, P. H., Bojsen-Møller, K. N., Dirksen, C., Serup, A. K., Kristensen, D. E., Frystyk, J., Clausen, T. R., Kiens, B., Richter, E. A., Madsbad, S., et al. (2015) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00228.2014 · Cited by 58
“Decreased peripheral insulin sensitivity is a common phenotypic characteristic of both obesity and type 2 diabetes (14) and has been attributed to impairment in insulin-stimulated glucose uptake/storage primarily in skeletal muscle (61).”
BackgroundMANAGEMENT OF ENDOCRINE DISEASE: Polycystic ovary syndrome and nonalcoholic fatty liver disease
Μacut, D., Antić, I. B., Bjekić-Macut, J., & Τζιόμαλος, Κ. (2017) · European Journal of Endocrinology · doi:10.1530/eje-16-1063 · Cited by 67
Optimisation of follow-up after metabolic surgery
Mingrone, G., Bornstein, S., & Le Roux, C. W. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30434-5 · Cited by 58
ACE2, angiotensin 1-7 and skeletal muscle: review in the era of COVID-19
Yamamoto, K. I., Takeshita, H., & Rakugi, H. (2020) · Clinical Science · doi:10.1042/cs20200486 · Cited by 63
Extracellular vesicle-associated miRNAs are an adaptive response to gestational diabetes mellitus
Nair, S., Guanzon, D., Jayabalan, N., Lai, A., Scholz‐Romero, K., Croft, P. K., Ormazábal, V., Palma, C., Diaz, E., McCarthy, E. A., et al. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-021-02999-9 · Cited by 64
Gut microbiota as the critical correlation of polycystic ovary syndrome and type 2 diabetes mellitus
Duan, L., An, X., Zhang, Y., Jin, D., Zhao, S., Zhou, R., Duan, Y., Zhang, Y., Liu, X., & Lian, F. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112094 · Cited by 70
Liver and muscle circadian clocks cooperate to support glucose tolerance in mice
Smith, J. G., Koronowski, K. B., Mortimer, T., Sato, T., Greco, C. M., Petrus, P., Verlande, A., Chen, S., Samad, M., Deyneka, E., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112588 · Cited by 60
“Instead, oxidation of carbohydrate is responsible for 90% of post-prandial glucose clearance.(44,45) To assess these mechanisms, we leveraged pyruvate tolerance tests.”
BackgroundSzekeres, Z., Nagy, A., Jahner, K., & Szabados, E. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25158214 · Cited by 77
“When obese individuals successfully lose weight, their muscle mass usually decreases as their body fat decreases [40].”
BackgroundCigarette Smoking: An Accessory to the Development of Insulin Resistance
Artese, A., STAMFORD, B. A., & Moffatt, R. J. (2017) · American Journal of Lifestyle Medicine · doi:10.1177/1559827617726516 · Cited by 76
“It results in inadequate control of blood glucose levels by normal insulin secretion and can result in increased insulin blood concentrations, known as hyperinsulinemia, to achieve the desired response.(4) This compensatory hyperinsulinemia will further activate negative feedback mechanisms causing a downregulation of…”
BackgroundGelidium elegans Extract Ameliorates Type 2 Diabetes via Regulation of MAPK and PI3K/Akt Signaling
Choi, J., Kim, K., Koh, E., & Lee, B.-Y. (2018) · Nutrients · doi:10.3390/nu10010051 · Cited by 61
Branched-chain ketoacid overload inhibits insulin action in the muscle
Biswas, D., Dao, K. T., Mercer, A., Cowie, A. M., Duffley, L., Hiani, Y. E., Kienesberger, P. C., & Pulinilkunnil, T. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.013121 · Cited by 63
“Skeletal and cardiac muscle insulin signaling and sensitivity are critical for metabolic homeostasis and organ function (21, 22).”
BackgroundVEGFB Promotes Myoblasts Proliferation and Differentiation through VEGFR1-PI3K/Akt Signaling Pathway
Ling, M., Quan, L., Lai, X., Lang, L., Li, F., Yang, X., Fu, Y., Feng, S., Yi, X., Zhu, C., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413352 · Cited by 57
Insulin resistance in clinical and experimental alcoholic liver disease
Carr, R. M., & Correnti, J. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12787 · Cited by 56
Wang, R., Pan, R., Zhang, W., Fu, J., Lin, J. D., & Meng, Z. (2017) · Protein & Cell · doi:10.1007/s13238-017-0442-2 · Cited by 63
“As such, impaired skeletal muscle insulin action and glucose utilization are the primary defects in the development of type 2 diabetes (DeFronzo and Tripathy, 2009).”
BackgroundSyncing Exercise With Meals and Circadian Clocks
Heden, T. D., & Kanaley, J. A. (2018) · Exercise and Sport Sciences Reviews · doi:10.1249/jes.0000000000000172 · Cited by 69
de Mendonça, M., Rocha, K. C. E., de Sousa, É., Pereira, B. M. V., Oyama, L. M., & Rodrigues, A. C. (2020) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00172.2020 · Cited by 61
Association of the triglyceride and glucose index with low muscle mass: KNHANES 2008–2011
Kim, J. A., Hwang, S. Y., Yu, J. H., Roh, E., Hong, S., Lee, Y., Kim, N. H., Yoo, H. J., Seo, J. A., Kim, N. H., et al. (2021) · Scientific Reports · doi:10.1038/s41598-020-80305-1 · Cited by 61
Jorquera, G., Russell‐Guzmán, J., Monsalves‐Álvarez, M., Cruz, G., Valladares-Ide, D., Basualto-Alarcón, C., Barrientos, G. C., Estrada, M., & Llanos, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22063254 · Cited by 70
“Under euglycemic and hyperinsulinemic conditions, ~80% of glucose uptake occurs in skeletal muscle [12,14].”
BackgroundEndothelin‐1 in the pathophysiology of obesity and insulin resistance
Jenkins, H. N., Rivera‐Gonzalez, O., Gibert, Y., & Speed, J. S. (2020) · Obesity Reviews · doi:10.1111/obr.13086 · Cited by 63
“states of IR, glycogenolysis and gluconeogenesis remain active even in the postprandial state, resulting in elevated glucose levels and eventual pathology.(5,6,8) Skeletal muscle takes up plasma glucose in an insulin-”
BackgroundRabbani, N., Xue, M., & Thornalley, P. J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042165 · Cited by 67
D’Souza, K., Nzirorera, C., Cowie, A. M., Varghese, G. P., Trivedi, P. C., Eichmann, T. O., Biswas, D., Touaibia, M., Morris, A. J., Aidinis, V., et al. (2018) · Journal of Lipid Research · doi:10.1194/jlr.m082008 · Cited by 55
“Because impaired insulin signaling and metabolism in skeletal muscle are primary drivers of systemic insulin resistance and hyperglycemia (50), we propose that the obesity-induced upregulation of ATX and LPA receptor signaling in muscle are critical mechanisms of insulin resistance.”
BackgroundSkeletal and Respiratory Muscle Dysfunctions in Pulmonary Arterial Hypertension
Riou, M., Pizzimenti, M., Enache, I., Charloux, A., Canuet, M., Andrès, E., Talha, S., Meyer, A., & Gény, B. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9020410 · Cited by 58
Pillon, N. J., Arane, K., Bilan, P. J., Chiu, T. T., & Klip, A. (2012) · Cell Communication and Signaling · doi:10.1186/1478-811x-10-30 · Cited by 53
“This is important because skeletal muscle is the major disposer of dietary insulin and a major determinant of glycemia, and wholebody insulin resistance arises only when skeletal muscle and/or the liver become resistant to the actions of insulin [22].”
BackgroundOzeki, Y., Masaki, T., Kamata, A., Miyamoto, S., Yoshida, Y., Okamoto, M., Gotoh, K., & Shibata, H. (2022) · Medicines · doi:10.3390/medicines9090047 · Cited by 53
“However, a decrease in MM may worsen the glycemic control of diabetic patients [8,9].”
BackgroundDunford, E. C., & Riddell, M. C. (2016) · Metabolites · doi:10.3390/metabo6040044 · Cited by 61
“Insulin resistance, which is an impaired response of insulin-sensitive tissues to insulin signalling, is a characteristic feature of T2DM and plays a key role in the pathogenesis of the disease [34,35].”
BackgroundLuo, Z., Fu, C., Li, T., Gao, Q., Miao, D., Xu, J., & Zhao, Y. (2021) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.0c07630 · Cited by 55
Glucose and lipid metabolism abnormalities in C ushing's syndrome
Salehidoost, R., & Korbonits, M. (2022) · Journal of Neuroendocrinology · doi:10.1111/jne.13143 · Cited by 65
“Skeletal muscle makes up 40% of the body's weight in lean people.(64) A significant portion of all glucose (70%–80%) in the body is consumed by skeletal muscle, both via insulin-related and insulin-independent mechanisms.”
BackgroundLi, Y., Wang, J., Gu, T., Yamahara, J., & Li, Y. (2014) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2014.03.016 · Cited by 61
Ruffino, J. S., Davies, N. A., Morris, K., Ludgate, M., Zhang, L., Webb, R., & Thomas, A. W. (2016) · European Journal of Applied Physiology · doi:10.1007/s00421-016-3414-y · Cited by 65
Basso, N., Soricelli, E., Castagneto-Gissey, L., Casella, G., Albanese, D., Fava, F., Donati, C., Tuohy, K., Angelini, G., La Neve, F., et al. (2016) · Diabetes · doi:10.2337/db16-0039 · Cited by 53
“Insulin resistance is the primary defect of type 2 diabetes and plays a central role in its pathogenesis, whereas b-cell failure develops only afterward (6).”
BackgroundDoan, H. V., Riyajan, S., Iyara, R., & Chudapongse, N. (2018) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-018-2328-0 · Cited by 67
Wei, J., Hao, Q., Chen, C., Li, J., Han, X., Lei, Z., Wang, T., Wang, Y., You, X., Chen, X., et al. (2020) · Theranostics · doi:10.7150/thno.45253 · Cited by 57
“2-DG: 2-deoxyglucose; 3′UTR: 3′untranslated regions; AAV9: adeno-associated virus 9; DEHP: di(2-ethylhexyl) phthalate; DMEM: dulbecco’s modified Eagle medium; EDCs: environmental endocrine-disruptingchemicals; FBS: fetal bovine serum; GSH: glutathione; IR: insulin resistance; Insr: insulin receptor; Irs1: insulin rece…”
BackgroundInfluentialUchiyama, S., Sada, Y., Mihara, S., Sasaki, Y., Sone, M., & Tanaka, Y. (2023) · Journal of Clinical Medicine Research · doi:10.14740/jocmr4987 · Cited by 52
Martemucci, G., Khalil, M., Luca, A. D., Abdallah, H., & D‘Alessandro, A. G. (2024) · Metabolites · doi:10.3390/metabo14060327 · Cited by 70
Increasing muscle mass to improve metabolism
McPherron, A. C., Guo, T., Bond, N. D., & Gavrilova, O. (2013) · Adipocyte · doi:10.4161/adip.22500 · Cited by 68
“where most of it is stored as glycogen or oxidized.(1,2) Intramyocellular lipid accumulation is correlated with insulin resistance and is detectable much earlier than the onset of type 2 diabetes mellitus (T2DM).”
BackgroundPalm, D. C., Rohwer, J. M., & Hofmeyr, J. S. (2012) · FEBS Journal · doi:10.1111/febs.12059 · Cited by 67
Adipose KLF15 Controls Lipid Handling to Adapt to Nutrient Availability
Matoba, K., Lü, Y., Zhang, R., Chen, E. R., Sangwung, P., Wang, B., Prosdocimo, D. A., & Jain, M. K. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.11.032 · Cited by 54
Raun, S. H., Ali, M., Kjøbsted, R., Møller, L. L. V., Federspiel, M. A., Richter, E. A., Jensen, T. E., & Sylow, L. (2018) · The Journal of Physiology · doi:10.1113/jp275602 · Cited by 52
“Furthermore, skeletal muscle is a major site of insulin resistance in obesity and type 2 diabetes (Bjornholm & Zierath, 2005; Biddinger & Kahn, 2006; Defronzo & Tripathy, 2009).”
BackgroundHuang, F., Chen, J., Wang, J., Zhu, P., & Lin, W. (2019) · BioMed Research International · doi:10.1155/2019/8171989 · Cited by 58
“, polysaccharides from dietary seaweed may be found effective for preventing T2DM.”
InfluentialMechanisms linking gut microbial metabolites to insulin resistance
Jang, H. R., & Lee, H. (2021) · World Journal of Diabetes · doi:10.4239/wjd.v12.i6.730 · Cited by 56
Brennan, A. M., Standley, R. A., Anthony, S. J., Grench, K. E., Helbling, N. L., DeLany, J. P., Cornnell, H. H., Yi, F., Stefanovic-Racic, M., Toledo, F. G. S., et al. (2022) · The Journals of Gerontology: Series A · doi:10.1093/gerona/glab240 · Cited by 51
Age-related metabolic and neurodegenerative changes in SAMP8 mice
Pačesová, A., Holubová, M., Hrubá, L., Strnadová, V., Neprašová, B., Pelantová, H., Kuzma, M., Železná, B., Kuneš, J., & Maletínská, L. (2022) · Aging · doi:10.18632/aging.204284 · Cited by 59
“Although plasma concentrations of insulin and glucose did not differ between SAMP8 and SAMR1 mice, decreased levels of the glucose transporter GLUT4 and attenuated activation of Akt were observed in skeletal muscle of 6- and 9-month-old SAMP8 mice, pointing to peripheral insulin resistance, which is usually observed i…”
BackgroundThe Diabetes Risk Phenotype of Young Women With Recent Gestational Diabetes
Rottenkolber, M., Ferrari, U., Holland, L., Aertsen, S., Kammer, N. N., Hetterich, H., Fugmann, M., Banning, F., Weise, M., Sacco, V., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3898 · Cited by 51
Cansby, E., Amrutkar, M., Mannerås-Holm, L., Nerstedt, A., Reyahi, A., Stenfeldt, E., Borén, J., Carlsson, P., Smith, U., Zierath, J. R., et al. (2013) · The FASEB Journal · doi:10.1096/fj.13-228494 · Cited by 53
“Skeletal muscle is the main tissue responsible for insulin-mediated glucose uptake, and insulin resistance measured with the clamp technique primarily reflects impairments in skeletal muscle (21).”
BackgroundWang, X., Feng, Z., Wang, X., Yang, L., Han, S., Cao, K. J., Xu, J., Zhao, L., Zhang, Y., & Liu, J. (2016) · Diabetologia · doi:10.1007/s00125-016-3919-2 · Cited by 51
Huang, L., Tepaamorndech, S., Kirschke, C. P., Newman, J. W. I., Keyes, W. R., Pedersen, T. L., & Dumnil, J. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.817692 · Cited by 54
“The homeostatic control of blood glucose levels is largely accomplished by the skeletal muscle, liver, and adipose tissue in which the muscle takes up and utilizes about 70 – 80% of daily absorbed glucose (12).”
BackgroundLow carbohydrate dietary approaches for people with type 2 diabetes-a narrative review
Wheatley, S. D., Deakin, T. A., Arjomandkhah, N. C., Hollinrake, P. B., & Reeves, T. E. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.687658 · Cited by 50
Heo, J., No, M., Cho, J., Choi, Y., Cho, E., Park, D., Kim, T., Kim, C., Seo, D. Y., Han, J., et al. (2021) · The FASEB Journal · doi:10.1096/fj.202002394r · Cited by 54
Tao, X., Niu, R., Lu, W., Zeng, X., Sun, X., & Liu, C. (2024) · International Journal of Obesity · doi:10.1038/s41366-024-01493-8 · Cited by 61
“On the other hand, insulin resistance obstacles peripheral glucose utilization and dysregu-lates protein turnover, especially in skeletal muscle and dietary nutrition quality [37].”
Pathophysiology and treatment of prediabetes and type 2 diabetes in youth
Bacha, F., Hannon, T. S., Tosur, M., Pike, J. M., Butler, A., Tommerdahl, K. L., & Zeitler, P. S. (2024) · Diabetes Care · doi:10.2337/dci24-0029 · Cited by 57
Cai, C., Qian, L., Jiang, S., Sun, Y., Wang, Q., Ma, D., Xiao, G., Li, B., Xie, S., Gao, T., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.16822 · Cited by 49
The current state of GPCR‐based drug discovery to treat metabolic disease
Sloop, K. W., Emmerson, P. J., Statnick, M. A., & Willard, F. S. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14157 · Cited by 51
High waist-to-hip ratio levels are associated with insulin resistance markers in normal-weight women
Benites-Zapata, V. A., Toro-Huamanchumo, C. J., Urrunaga-Pastor, D., Guarnizo-Poma, M., Lazaro-Alcantara, H., Paico-Palacios, S., Pantoja-Torres, B., & Ranilla-Seguin, V. D. C. (2019) · Diabetes & Metabolic Syndrome: Clinical Research & Reviews · doi:10.1016/j.dsx.2018.11.043 · Cited by 49
Liver and insulin resistance: New wine in old bottle!!!
Patel, B. M., & Goyal, R. K. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.172657 · Cited by 54
Acetyl-CoA and Metabolite Fluxes Regulate White Adipose Tissue Expansion
Felix, J. B., Cox, A. R., & Hartig, S. M. (2021) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2021.02.008 · Cited by 62
mTORC1 and the regulation of skeletal muscle anabolism and mass
Adegoke, O. A. J., Abdullahi, A., & Tavajohi-Fini, P. (2012) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/h2012-009 · Cited by 49
Wu, C. J., Xu, G., Tsai, S., Freed, W. J., & Lee, C. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.11.055 · Cited by 53
Lee, W., Lee, H., Jang, H. B., Kim, H., Ban, H., Kim, K. Y., Nam, M. S., Choi, J. S., Lee, K., Cho, S. B., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-20549-0 · Cited by 49
Maykish, A., & Sikalidis, A. K. (2020) · Journal of Personalized Medicine · doi:10.3390/jpm10010019 · Cited by 58
Wang, W., Yang, W., Dai, Y. M., Liu, J., & Chen, Z. (2023) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.2c08835 · Cited by 54
The Multiple Roles of Lactate in the Skeletal Muscle
Bartoloni, B., Mannelli, M., Gamberi, T., & Fiaschi, T. (2024) · Cells · doi:10.3390/cells13141177 · Cited by 80
“Regarding insulin resistance, it is considered one of the main challenges leading to the development of type 2 diabetes [73].”
BackgroundThe disposition index: adjustment for peripheral vs. hepatic insulin sensitivity?
Færch, K., Brøns, C., Alibegovic, A. C., & Vaag, A. A. (2010) · The Journal of Physiology · doi:10.1113/jphysiol.2009.184028 · Cited by 55
“…high supra-physiological insulin infusion rates during euglycaemic clamps (40–80 mU m−2 min−1), hepatic glucose production is almost fully suppressed (DeFronzo et al. 1979), and 80–90% of glucose disposal occurs in peripheral tissues (predominantly skeletal muscles) (DeFronzo & Tripathy, 2009).”
BackgroundWhite, A. T., Philp, A., Fridolfsson, H. N., Schilling, J. M., Murphy, A. N., Hamilton, D. L., McCurdy, C. E., Patel, H. H., & Schenk, S. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00001.2014 · Cited by 53
“Given the potential benefit of SIRT1 activation for the treatment of insulin resistance (16, 25, 26, 39), and the importance of skeletal muscle in postprandial glycemia (14), we investigated whether overexpression of SIRT1 in skeletal muscle is sufficient to prevent obesity-related impairments in glucose tolerance and…”
BackgroundPro-resolving actions of SPM in adipose tissue biology
Clària, J., López‐Vicario, C., Rius, B., & Titos, E. (2017) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2017.03.004 · Cited by 52
Exocytosis proteins as novel targets for diabetes prevention and/or remediation?
Aslamy, A., & Thurmond, D. C. (2017) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00002.2017 · Cited by 47
Associations of body fat and skeletal muscle with hypertension
Han, T. S., Algindan, Y., Govan, L., Hankey, C., & Lean, M. E. J. (2018) · Journal of Clinical Hypertension · doi:10.1111/jch.13456 · Cited by 56
D’Souza, K., Mercer, A., Mawhinney, H., Pulinilkunnil, T., Udenigwe, C. C., & Kienesberger, P. C. (2020) · Nutrients · doi:10.3390/nu12020425 · Cited by 47
Veelen, A., Erazo‐Tapia, E., Oscarsson, J., & Schrauwen, P. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101158 · Cited by 53
He, P., Ye, Z., Liu, M., Li, H., Zhang, Y., Zhou, C., Wu, Q., Zhang, Y., Yang, S., Liu, C., et al. (2023) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13180 · Cited by 55
“Muscle mass was inversely associated with insulin resistance.(35) Systemic and podocyte-specific insulin resistance has been reported to be an important factor in kidney dysfunction.”
BackgroundSun, W., Kou, X., Wu, C., Fan, G., Li, T., Cheng, X., Xu, K., Suo, A., & Tao, Z. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.124301 · Cited by 48
Coaxing stem cells for skeletal muscle repair
McCullagh, K. J. A., & Perlingeiro, R. C. R. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.07.007 · Cited by 54
“For instance, skeletal muscle is a major regulator of blood glucose levels, and consequently, a defect in the mechanism of muscle insulin cell signaling is the main contributor to type II diabetes [1,2].”
BackgroundSvendsen, P. F., Jensen, F. K., Holst, J. J., Haugaard, S. B., Nilas, L., & Madsbad, S. (2012) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365513.2012.691542 · Cited by 47
Kim, O. Y., Chung, J. Y., & Song, J. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104411 · Cited by 43
Sarcoplasmic reticulum and calcium signaling in muscle cells: Homeostasis and disease
Bravo, R., Parra, V., Muñoz‐Córdova, F., Sánchez-Aguilera, P., Garrido, V., Contreras‐Ferrat, A. E., Chiong, M., & Lavandero, S. (2020) · International review of cytology · doi:10.1016/bs.ircmb.2019.12.007 · Cited by 47
“However, in pathological conditions, skeletal muscle loses its capacity to respond to insulin, in a process known as insulin resistance, the first step for the development of type-2 diabetes (Defronzo and Tripathy, 2009).”
BackgroundMutlak, Y. E., Aweida, D., Volodin, A., Ayalon, B., Dahan, N., Parnis, A., & Cohen, S. (2020) · Nature Communications · doi:10.1038/s41467-020-14895-9 · Cited by 59
Xu, L., Chen, Y., Chen, Z., et al. (2020) · Journal of Food Science · doi:10.1111/1750-3841.15485 · Cited by 47
The role of mitochondrial reactive oxygen species in insulin resistance
Ayer, A., Fazakerley, D. J., James, D. E., & Stocker, R. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.11.007 · Cited by 56
Glutamine Regulates Skeletal Muscle Immunometabolism in Type 2 Diabetes
Dollet, L., Kuefner, M., Caria, E., Rizo‐Roca, D., Pendergrast, L. A., Abdelmoez, A. M., Karlsson, H., Bjrnholm, M., Dalbram, E., Treebak, J. T., et al. (2022) · Diabetes · doi:10.2337/db20-0814 · Cited by 61
“Skeletal muscle accounts for the majority of insulin-stimulated whole-body glucose disposal (3).”
BackgroundNucleotides Released From Palmitate-Challenged Muscle Cells Through Pannexin-3 Attract Monocytes
Pillon, N. J., Li, Y. E., Fink, L. N., Brozinick, J. T., Nikolayev, A., Kuo, M., Bilan, P. J., & Klip, A. (2014) · Diabetes · doi:10.2337/db14-0150 · Cited by 53
“Surprisingly, equivalent studies in skeletal muscle had been relatively scant despite this tissue being responsible for the majority of postprandial glucose use (3).”
BackgroundAlzheimer's disease: Is this a brain specific diabetic condition?
Rani, V., Deshmukh, R. R., Jaswal, P., Kumar, P., & Bariwal, J. B. (2016) · Physiology & Behavior · doi:10.1016/j.physbeh.2016.05.041 · Cited by 56
Mayor, F., Cruces‐Sande, M., Arcones, A. C., Vila‐Bedmar, R., Briones, A. M., Salaíces, M., & Murga, C. (2017) · Cellular Signalling · doi:10.1016/j.cellsig.2017.04.002 · Cited by 57
Kleinert, M., Parker, B. L., Jensen, T. E., Raun, S. H., Pham, P., Han, X., James, D. E., Richter, E. A., & Sylow, L. (2018) · Scientific Reports · doi:10.1038/s41598-018-28540-5 · Cited by 46
Chen, X., Guo, J., Han, P., Fu, L., Jia, L., Yu, H., Yu, X., Hou, L., Wang, L., Zhang, W., et al. (2018) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2018.07.017 · Cited by 47
Diabetes, body fat, skeletal muscle, and hypertension: The ominous chiasmus?
Shu, J., Matarese, A., & Santulli, G. (2018) · Journal of Clinical Hypertension · doi:10.1111/jch.13453 · Cited by 50
(2020) · Advances in clinical chemistry · doi:10.1016/bs.acc.2019.07.012 · Cited by 46
Mondal, V., Hosen, Z., Hossen, F., Siddique, A. E., Tony, S., Islam, Z., Islam, M. S., Hossain, S., Islam, K., Sarker, M. K., et al. (2020) · Environment International · doi:10.1016/j.envint.2020.105890 · Cited by 47
Quan, X., Wang, J., Liang, C., Zheng, H., & Zhang, L. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.06.065 · Cited by 53
Xu, Z., Yang, S., Tan, Y., Zhang, Q., Wang, H., Tao, J., Liu, Q., Wang, Q., Feng, W., Li, Z., et al. (2025) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-025-05379-9 · Cited by 75
“In skeletal muscle, insulin exerts its effects through the PI3K-AKT signaling pathway, facilitating glucose uptake and glycogen synthesis [204].”
Liu, H., Mahmood, S., Srinivasan, M., Smiraglia, D. J., & Patel, M. S. (2013) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2013.05.002 · Cited by 53
“Skeletal muscle plays a pivotal role for glucose uptake and in the maintenance of whole body glucose homeostasis [40].”
BackgroundDifferential control of muscle mass in type 1 and type 2 diabetes mellitus
Sala, D., & Zorzano, A. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-1954-7 · Cited by 47
“In fact, skeletal muscle, which is not only the major tissue in charge of glucose uptake upon insulin stimulation but also the main protein reservoir of the organism, is one of the tissues most severely affected by this disease [11].”
BackgroundmicroManaging glucose and lipid metabolism in skeletal muscle: Role of microRNAs
Massart, J., Katayama, M., & Krook, A. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2016.05.006 · Cited by 47
Promoting Glucose Transporter-4 Vesicle Trafficking along Cytoskeletal Tracks: PAK-Ing Them Out
Tunduguru, R., & Thurmond, D. C. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00329 · Cited by 52
Han, S. J., Boyko, E. J., Kim, S., Fujimoto, W. Y., Kahn, S. E., & Leonetti, D. L. (2018) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2018.0022 · Cited by 48
“Skeletal muscle is a major site for glucose uptake and deposition, and hence plays an important role in the regulation of blood glucose levels [3].”
Background
Metadata
- Authors
- DeFronzo, R. A., & Tripathy, D.
- Affiliations
- The University of Texas at San Antonio Health Science Center (US)
- Corresponding author
- Tripathy, Devjit
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2009-11-01
- Volume
- 32
- Issue
- suppl_2
- Pages
- S157-S163
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2811436
- OpenAlex
- W2170869159
- Cited by
- 2,102
- References
- 115
- Citations by year
- 2026: 149 · 2025: 188 · 2024: 187 · 2023: 161 · 2022: 200 · 2021: 199 · 2020: 161 · 2019: 146 · 2018: 166 · 2017: 132 · 2016: 119 · 2015: 99 · 2014: 72 · 2013: 54 · 2012: 29
- FWCI
- 2.87
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- skeletal muscle insulin resistance, type 2 diabetes, insulin resistance, beta-cell failure, type 2 diabetes pathogenesis, glucose tolerance, hyperglycemia
- MeSH terms
- Insulin Secretion, Blood Glucose, Diabetes Mellitus, Type 2, Fatty Acids, Nonesterified, Homeostasis, Humans, Insulin, Insulin Resistance, Glucose Clamp Technique, Muscle, Skeletal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-09-30, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-09-30 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.